Marijuana Stocks & Public Companies

Stocks & Public Company News

GW Pharma’s latest clinical trial successful, stock soars

British cannabis company GW Pharmaceuticals has conducted a successful clinical trial in which it treated epileptic children with one of its marijuana-based drugs, triggering a surge in the company’s stock price. According to Reuters, tested doses of GW Pharmaceutical’s drug Epidiolex “were found to have induced a statistically significant improvement in reducing seizures” in patients […]

Read More

Medical Marijuana Inc. partners with CannaNative on CBD product

California-based Medical Marijuana Inc. and Native American company CannaNative have put together a hemp-derived CBD product line to be sold on tribal lands. The companies said in a news release Monday that Medical Marijuana Inc. and its HempMeds subsidiary will produce the product line, which will be sold under the CannaNative brand. It will be offered […]

Read More

Canadian MJ companies raise tens of millions in financing

Within the span of a week and a half, a trio of Canadian medical cannabis producers announced they had all raised seven-figure amounts to expand their businesses. First it was Aphria, which revealed on July 28 that it had entered into a “bought deal” that would net it CA$25 million, in exchange for 12.5 million […]

Read More

CO online wholesaler partnering with cannabis software firms

Colorado-based online wholesale platform Cannabase has entered into exclusive partnerships with seed-to-sale tracking software companies MJ Freeway and BioTrackTHC. The partnership, announced by the companies, will bring new weight to Cannabase’s pricing and inventory information, given that it will now be backed by MJ Freeway’s and BioTrackTHC’s data. In a pair of news releases, Cannabase […]

Read More

Canadian MJ grower to list on major stock exchange

In what could be a first in both the cannabis industry and stock market history, a large marijuana cultivation company will list on a major North American stock exchange. Canopy Growth Corp., one of Canada’s biggest licensed medical marijuana companies, started trading on the Toronto Stock Exchange (TMX) Tuesday under the ticker symbol CGC, according […]

Read More

Australian MMJ company aims to raise $4M for human trials

A publicly traded Australian pharmaceutical and biotech company that recently entered the medical marijuana sector aims to raise about $4.1 million (AUS $5.4 million) to support MMJ trials on human subjects. If successful, Medlab Clinical plans to spend the money to accelerate a program of human trials of cannabis-based pain management therapy for cancer patients […]

Read More

Steep Hill Nixes Testing Labs Deal With Pazoo

Steep Hill Labs, a prominent marijuana testing company, has severed all contracts with New Jersey-based Pazoo, which had struck a deal to operate Steep Hill-branded cannabis testing labs in Colorado, Nevada and Oregon. In a press release, Steep Hill said the relationship was ended because Pazoo – a New Jersey-based testing lab and wellness company – […]

Read More

Week in Review: California is official, GW’s epilepsy drug & Illinois resignation

By Omar Sacirbey and John Schroyer California’s recreational marijuana campaign makes the November ballot, GW Pharmaceuticals’ MJ-based epilepsy drug could play a role in DEA rescheduling, and a possible new dawn in Illinois’ medical cannabis program. Here’s a closer look at some notable developments in the marijuana industry over the past week.

Read More

Medical Cannabis Company GW Pharma’s Stock Again Jumps

GW Pharmaceuticals – a publicly traded British medical cannabis company conducting clinical trials to determine how effective its medications are against epilepsy – watched its stock surge once again in response to a successful round of testing. News Monday that a phase 3 trial was helpful at treating patients with Lennox-Gastaut Syndrome, a type of epilepsy, […]

Read More